Iron isomaltoside 1000

DB12208ApprovedInvestigationalWithdrawnSmall molecule

Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney...

Also known as: Monofer

Resolves to

Compound

UNII3M6325NY1RCAS1370654-58-2

What you can answer from here — as of August 16, 2026

65Drug interactionsStructured to mechanism, not free text

60Clinical trialsPhase, status and sponsor resolved per trial

4Structured indicationsCondition, population, route and combination as fields, not prose

7Marketed productsAcross 1 country and 1 labeller

8+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Iron isomaltoside 1000, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account